the aid library

LIST OPTIONS

Filter

2833

Surveillance der Gesundheit geflüchteter Menschen in Aufnahmeeinrichtungen

Bozorgmehr, K.; S. Rohleder, M. Qreini, et al. (2021) CC

Multizentrische Analyse des Erkrankungsspektrums und der Versorgungsqualität anhand dezentralisierter Routinedaten des Verbunds PriCarenet Health Equity Studies & Migration Report Series 2021-03

Download (609)

View PDF (518)

Standard treatment guidelines Otorhinolarygology (ENT)

Ministry of Health & Family Welfare, India (2020) C1

Accessed Febr.6, 2020

Download (800)

View PDF (524)

Neonatal Care Clinical Guidelines

UNICEF, World Health Organisation (WHO) (2018) CC

This first edition of our national neonatal care clinical guidelines is an initiative that aims to ensure that all the neonates in the Kingdom of Eswatini are offered standard, best quality of care and the best possible start in life. The guidelines have been formulated from various global sources a... more

Download (4097)

View PDF (2633)

THE UNANI PHARMACOPOEIA OF INDIA

Pharmacopoeia Commission for Indian Medicine & Homoeopathy, Ministry of AYUSH, Government of India (2016) C1

Download (920)

View PDF (1923)

Adolescent HIV Care and Treatment: A Training Curriculum for Health Workers . Module 6 Participant

ICAP; CDC; University Teaching Hospital, et al. (2011)

Download (379)

View PDF (705)

Encuesta 2017-2018: Conocimientos, actitudes y práticas de los pobladores del Chaco paraguayo sobre las enfermedades infecciosas desatentidas y el dengue, Resultados

Organización Panamericana de la Salud; World Health Organization WHO (2018) C_WHO

Paraguay muestra avances en el compromiso asumido, de avanzar hacia la Salud Uni¬versal. La experiencia ha demostrado que el proceso puede acelerarse cuando existe un fuerte involucramiento social. En este marco se realizó un llamado a los líderes del MSPYBS, la sociedad civil y público en gener... more

Download (390)

View PDF (549)

Inheriting a sustainable world? Atlas on children’s health and environment.

World Health Organization (WHO) (2018) C_WHO

In 2015, 26% of the deaths of 5.9 million children who died before reaching their fifth birthday could have been prevented through addressing environmental risks – a shocking missed opportunity. The prenatal and early childhood period represents a window of particular vulnerability, where enviro... more

External Link

Organizing trichiasis surgical outreach

International Coalition for Trachoma Control ICTC (2015) CC

A key component of elimination is to reduce the number of unmanaged trachomatous trichiasis cases to less than 1 per 1,000 population in affected areas. This will require not only a large increase in the number of surgeries performed, but also improvements in the quality of surgery and in the e... more

Download (1460)

View PDF (1426)

National Technical Guidelines for Integrated Disease Surveillance and Response Liberia

Ministry of Health, Liberia, World Health Organization (WHO), and Centers for Disease Control and Prevention (CDC) (2021) C_WHO

3rd edition

Download (445)

View PDF (485)

Child Protection Action Plan 2015-2020

International Federation of Red Cross and Red Crescent Societies (2016) C1

This document aims to define a practical plan of action for the IFRC Secretariat to effectively integrate child protection, as a minimum standard, within its organizational systems and development, protracted crisis and emergency operations. The timeline for the action plan is 2015 to the end of 202... more

Download (576)

View PDF (663)

Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended

World Health Organisation (WHO) (2023) C_WHO

Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based, ... more

Download (989)

View PDF (550)

Prevención, diagnóstico, tratamiento y control de la tuberculosis Guía de Práctica Clínica Segunda

Organización Mundial de la Salud OMS; Ministerio de Salud Ecuador (2018) CC

Considerando los cambios estratégicos en el abordaje de la salud pública y de la atención primaria de la salud, la prevención y el control de la tuberculosis en Ecuador genera un cambio en la parte organizacional y en la prestación de servicios con enfoque en grupos vulnerables y/o con factores... more

External Link

Coronavirus (COVID-19) - Imperial College London

Imperial College London Imperial Collage London (2020) C2

Last updated Friday 20 March

Download (472)

View PDF (500)

Establishing community-led monitoring of HIV services — Principles and process

UNAIDS (2021) CC

25 February 2021 This technical guidance is a living document that builds on guidelines and reports of the UNAIDS Joint Programme. The definitions contained herein are working definitions that are subject to change. Updates will also be added further to the work of the multistakeholder Task Team on... more

Download (385)

View PDF (604)

A Framework for Voluntary Medical Male Circumcision - Effective HIV Prevention and a gateway t improved adolesecent boys' & Men's health in Eastern and Southern Africa by 2021

World Health Organization (WHO); UNAIDS World Health Organization (WHO); UNAIDS (2016) C_WHO

Policy Brief VMMC 2021

Download (1020)

View PDF (1482)

Nepal: Leprosy Guideline 2070 (Nepali Version)
recommended

Government of Nepal Ministry of Health Department of Health Services Leprosy Control Division (2013) C1

Download (852)

View PDF (1191)

Independent Monitoring Board of the Global Polio Eradication Initiative (Fifteenth Report: December 2017)

Global Polio Eradication Initiative (2017) C1

The report reviews progress with the task of planning and implementing measures necessary to secure a completely polio-free world. It also examines actions aimed at ensuring successful transfer of polio assets, innovations developed and lessons learned to countries’ public health programmes and ot... more

Download (572)

View PDF (770)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030 recommended

Nepal: Leprosy Guideline 2070 (Nepali Version) recommended

Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended

Nepal: Leprosy Guideline 2070 (Nepali Version)
recommended